23 February 2017
News and Views
Links and Services
The latest issue of the Alimentary Pharmacology & Therapeutics investigates retesting for latent tuberculosis in patients with IBD treated with TNF-α inhibitors.
Patients treated with TNF-α inhibitors are at high risk of reactivation of latent tuberculos
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors